Harvey Montijo, MD
Orthopaedic Surgery · Royal Palm Beach, FLNPI 1205818457
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $68,928 of the $82,920 with a category attached, or 83.1%. 32 manufacturers reported payments, led by In2bones USA, LLC at 47.4% of the total. 2025 is the largest year on record at $17,892, 2.9 times the $6,231 reported in 2019.
Across 257 payments — averaging $322.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- In2bones USA, LLC$39K
- Linvatec Corporation$30K
- UOC USA Inc$8K
- Amgen$2K
- Stryker$1K
- Johnson & Johnson$747
- plus $2K from 26 others
Across 6 payments — averaging $30,475 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kyocera Medical Technologies, Inc.$183K
What the payments were for
- Royalty or licence$68,92883%
- Consulting fees$7,7509%
- Food & beverage$6,2438%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| In2bones USA, LLC | 16 | $39,333 |
| Linvatec Corporation | 10 | $29,595 |
| UOC USA Inc | 6 | $8,072 |
| Amgen(2 entities) | 123 | $1,536 |
| Stryker | 20 | $1,432 |
| Johnson & Johnson | 34 | $747 |
| Kyocera Medical Technologies, Inc. | 3 | $472 |
| Zimmer Biomet | 5 | $300 |
| Smith+Nephew | 10 | $265 |
| Sanara Medtech Inc. | 1 | $198 |
| Southern Edge Orthopaedics, Inc. | 1 | $183 |
| Carbofix Orthopedics Inc | 2 | $122 |
| Captiva Spine Inc | 1 | $98 |
| Nevro Corp. | 1 | $96 |
| Medacta USA, Inc. | 1 | $60 |
| Pacira Therapeutics, Inc. | 3 | $56 |
| Bioventus LLC | 3 | $43 |
| Vericel Corporation | 2 | $37 |
| Orthalign Inc | 1 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Molnlycke Health Care US, LLC | 1 | $25 |
| Zyla Life Sciences, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| Flower Orthopedics Coporation | 1 | $18 |
| Baudax Bio Inc. | 1 | $18 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Orthogenrx Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| Zimvie Inc. | 1 | $13 |
| Electronic Waveform Lab, Inc. | 1 | $12 |
| Radius Health, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoLink$39,333
- NeoSpan$19,818
- COLINK AFX$15,973
- NEOSPAN SUPERELASTIC COMPRESSION STAPLE W/INSTRUMENTS, SIZE 10X10X10$13,621
- COLINK PLATING SYSTEM$13,621
- U-Star II$5,250
- U2 PF+$2,500
- CellerateRx$198
- ORTHOLOC 3DI$173
- INSIGNIA$172
- MAKO$154
- U2, Conformity, U-Motion II and USTAR II$146
- Navio Surgical System$130
- Legion$130
- Persona Revision$125
- MF INSTRUMENTS$120
- U2, Conformity, USTAR II and T Mini$119
How this compares
$82,920 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 237 | $4,755 |
| Diclofenac Sodium | 299 | $4,461 |
| Methocarbamol | 442 | $4,171 |
| Gabapentin | 638 | $3,303 |
| Meloxicam | 714 | $2,432 |
| Lidocaine | 17 | $1,205 |
| Ibuprofen | 140 | $1,161 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $1,093 |
| Mupirocin | 143 | $1,017 |
| Tramadol Hcl | 156 | $939 |
| Celecoxib | 50 | $889 |
| Cyclobenzaprine Hcl | 58 | $614 |
| Oxycodone Hcl | 30 | $334 |
| Prednisone | 62 | $287 |
| Tizanidine Hcl | 55 | $276 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Royal Palm Beach
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.